Abstract |
Testicular cancer is the most common cancer in men aged 15 to 40 years in the United States, Canada, and many European countries. Given the excellent prognosis of most men with testicular cancer, updates in care after treatment have become very important. This article provides a review of the available evidence, integrated with expert medical judgment, in the area of testicular cancer follow-up.
|
Authors | Clair J Beard, Shilpa Gupta, Robert J Motzer, Elizabeth K O'Donnell, Elizabeth R Plimack, Kim A Margolin, Charles J Ryan, Joel Sheinfeld, Darren R Feldman |
Journal | Journal of the National Comprehensive Cancer Network : JNCCN
(J Natl Compr Canc Netw)
Vol. 13
Issue 6
Pg. 811-22
(Jun 2015)
ISSN: 1540-1413 [Electronic] United States |
PMID | 26085395
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Copyright | Copyright © 2015 by the National Comprehensive Cancer Network. |
Topics |
- Combined Modality Therapy
- Consensus
- Disease Management
- Follow-Up Studies
- Humans
- Interdisciplinary Communication
- Male
- Testicular Neoplasms
(therapy)
- Treatment Outcome
|